Robert Andretti
Chief Financial Officer
Replay available
Fennec Pharmaceuticals Inc. (FENC) Q4 2024 Earnings Call
Fennec Pharmaceuticals Inc. (NASDAQ: FENC) Q4 2024 earnings conference call, held 2025-03-10. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Jeff Hackman
Chief Executive Officer & Board Member
Chase Knickerbocker
Analyst
Raghuram Chauhan
Analyst, HC Wainwright
Felix Ampuma
Analyst (in lieu of Sudan Luganathan, Stevens)
Michael Okunwich
Analyst, Maxim Group
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Fennec Pharmaceuticals Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:05.478 Good morning, ladies and gentlemen, and welcome to Fennec Pharmaceutical's fourth quarter 00:00:05.478 -- 00:00:10.686 in full year 2024 earnings and corporate update conference call. 00:00:10.686 -- 00:00:15.412 At this time, all participants are in a listen-only mode. 00:00:15.412 -- 00:00:21.460 Later, we will conduct a question and answer session and instructions on how to participate 00:00:21.460 -- 00:00:26.628 will be given at that time. As a reminder, today's conference call is 00:00:26.628 -- 00:00:32.039 being recorded. Now, I would like to turn the conference over to Fennec's Chief 00:00:32.039 -- 00:00:37.926 Financial Officer, Robert Andretti. Please go ahead. 00:00:37.926 -- 00:00:41.430 Thank you, Operator, and good morning, everyone. 00:00:41.430 -- 00:00:46.416 We appreciate you joining us today for Fennec Pharmaceutical's fourth quarter and full 00:00:46.416 -- 00:00:51.722 year 2024 earnings conference call, during which we will review 00:00:51.722 -- 00:00:56.782 our financial results as well as provide a general business update. 00:00:56.782 -- 00:01:01.848 Joining me from Fennec this morning is our Chief Executive Officer and Board Member, 00:01:01.848 -- 00:01:03.589 Jeff Hackman. 00:01:03.589 -- 00:01:07.814 Before we begin, I would like to remind you that during this call, the company will be 00:01:07.814 -- 00:01:12.880 making forward-looking statements that are subject to risks and uncertainties that may 00:01:12.880 -- 00:01:18.266 cause actual results to differ from the results discussed in the forward-looking statements. 00:01:18.266 -- 00:01:23.530 Reference to these risks and uncertainties are made in today's press release and disclosed 00:01:23.530 -- 00:01:28.297 in detail in the company's periodic...